Any solid tumor

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organization(s)	Biomarker(s)	Cancer type	Therapy(ies)
FDA (2)	BRAF p.V600E	Any solid tumor	Dabrafenib, Trametinib
FDA (1)	dMMR	Any solid tumor	Dostarlimab
EMA (1) FDA (1)	v::NTRK1	Any solid tumor	Entrectinib
EMA (1) FDA (1)	v::NTRK2	Any solid tumor	Entrectinib
EMA (1) FDA (1)	v::NTRK3	Any solid tumor	Entrectinib
EMA (1) FDA (1)	v::NTRK1	Any solid tumor	Larotrectinib
EMA (1) FDA (1)	v::NTRK2	Any solid tumor	Larotrectinib
EMA (1) FDA (1)	v::NTRK3	Any solid tumor	Larotrectinib
FDA (1)	dMMR	Any solid tumor	Pembrolizumab
FDA (1)	MSI-H	Any solid tumor	Pembrolizumab
FDA (1)	TMB-H (>= 10 mutations / Mb)	Any solid tumor	Pembrolizumab
EMA (1) FDA (1)	v::NTRK1	Any solid tumor	Repotrectinib
EMA (1) FDA (1)	v::NTRK2	Any solid tumor	Repotrectinib
EMA (1) FDA (1)	v::NTRK3	Any solid tumor	Repotrectinib
EMA (1) FDA (1)	v::RET	Any solid tumor	Selpercatinib
FDA (1)	HER2-positive	Any solid tumor	Trastuzumab deruxtecan